0000000000844995

AUTHOR

Juan Paulo Navarro

showing 3 related works from this author

Differential Effect of Glycosylated Hemoglobin Value and Antidiabetic Treatment on the Risk of 30-day Readmission Following a Hospitalization for Acu…

2015

In patients with heart failure and type 2 diabetes, low glycosylated hemoglobin has been related with higher risk of mortality but information regarding morbidity is scarce. We sought to evaluate the association between glycosylated hemoglobin and 30-day readmission in patients with type 2 diabetes and acute heart failure.Glycosylated hemoglobin was measured before discharge in 835 consecutive patients with acute heart failure and type 2 diabetes. Cox regression analysis adapted for competing events was used.Mean (standard deviation) age was 72.9 (9.6) years and median glycosylated hemoglobin was 7.2% (6.5%-8.0%). Patients treated with insulin or insulin/sulfonylurea/meglitinides were 41.1%…

Malemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentType 2 diabetesGastroenterologyPatient ReadmissionRisk AssessmentInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsAgedRetrospective StudiesGlycated HemoglobinHeart FailureProportional hazards modelbusiness.industryInsulinHazard ratioGeneral Medicinemedicine.diseasePrognosisSulfonylureaConfidence intervalPatient DischargeSurvival RateEndocrinologyDiabetes Mellitus Type 2SpainHeart failureAcute DiseaseFemalebusinessFollow-Up StudiesRevista espanola de cardiologia (English ed.)
researchProduct

Efecto diferencial de la glucohemoglobina y el tratamiento antidiabético sobre el riesgo de reingreso a 30 días después de un ingreso por insuficienc…

2015

Introduccion y objetivos En los pacientes con insuficiencia cardiaca y diabetes tipo 2, las cifras bajas de glucohemoglobina se han relacionado con un riesgo mas elevado de mortalidad, pero la informacion relativa a la morbilidad es escasa. El objetivo de este estudio fue evaluar la asociacion existente entre la glucohemoglobina y el reingreso en un plazo de 30 dias en los pacientes con diabetes tipo 2 e insuficiencia cardiaca aguda. Metodos Se determino la glucohemoglobina antes del alta en 835 pacientes consecutivos con insuficiencia cardiaca aguda y diabetes tipo 2. Se utilizo un analisis de regresion de Cox adaptado para eventos competitivos. Resultados La media de edad fue de 72,9 ± 9,…

business.industryMedicineCardiology and Cardiovascular MedicinebusinessHumanitiesRevista Española de Cardiología
researchProduct

The Effects of Selective Stellate Ganglion Manipulation on Ventricular Refractoriness and Excitability

1992

The effects of selective stellate ganglion stimulation or stellectomy on ventricular excitability were studied in 30 open chest mongrel dogs anesthetized with alpha-chloralose. The effective refractory period (ERP) and strength interval curves (stimulus intensity [S2] = twice the diastolic threshold [ERP], and 2, 3, 5, 7, and 14 mA) were determined using bipolar epicardial electrodes placed in the mid-anterior wall of the right ventricle (RV) and the mid-posterolateral wall of the left ventricle (LV) during left stellate ganglion stimulation (LSGSt, n = 8) or right stellate ganglion stimulation (RSGSt, n = 8), or after left stellectomy (LSGEx, n = 7) or right stellectomy (RSGEx, n = 7). LSG…

MaleSympathetic nervous systemmedicine.medical_specialtyRefractory Period Electrophysiologicalgenetic structuresStellate GanglionDiastoleStimulationbehavioral disciplines and activitiesDogsHeart Conduction SystemInternal medicineAnimalsVentricular FunctionMedicineAnalysis of VarianceCardiac electrophysiologybusiness.industrymusculoskeletal neural and ocular physiologyCardiac Pacing ArtificialEffective refractory periodHeartGeneral MedicineElectric StimulationGanglionectomyGanglionElectrophysiologymedicine.anatomical_structureVentricleAnesthesiaStellate ganglionCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPacing and Clinical Electrophysiology
researchProduct